BRUKER CORPORATION Legal Fees
BRUKER CORPORATION (BRKR) reported Legal Fees of $1.10 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2020-08-07
- BRUKER CORPORATION legal fees for the quarter ending 2020-06-30 was $1.10M.
- BRUKER CORPORATION legal fees for the quarter ending 2020-03-31 was $3.40M.
- BRUKER CORPORATION legal fees for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- BRUKER CORPORATION legal fees for the quarter ending 2015-09-30 was $400.00K, a 33.33% increase year-over-year.
- BRUKER CORPORATION legal fees for fiscal 2019 was $2.10M, a 53.33% decline from fiscal 2018.
- BRUKER CORPORATION legal fees for fiscal 2018 was $4.50M, a 2150.00% increase from fiscal 2017.
- BRUKER CORPORATION legal fees for fiscal 2017 was $200.00K.
- BRUKER CORPORATION legal fees for fiscal 2015 was $400.00K, a 87.50% decline from fiscal 2014.
| Period end | Legal Fees 3 month | Legal Fees 6 month | Legal Fees 9 month | Legal Fees 12 month |
|---|---|---|---|---|
| 2020-06-30 | $1.10M 10-Q · filed 2020-08-07 | $4.50M 10-Q · filed 2020-08-07 | ||
| 2020-03-31 | $3.40M 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | $2.10M 10-K · filed 2020-03-27 | |||
| 2018-12-31 | $4.50M 10-K · filed 2020-03-27 | |||
| 2017-12-31 | $200.00K 10-K · filed 2020-03-27 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $400.00K derived: sum of 2 quarters · filed 2018-03-16 | $400.00K 10-K · filed 2018-03-16 | |
| 2015-09-30 | $400.00K 10-Q · filed 2016-11-09 | $400.00K 10-Q · filed 2016-11-09 | ||
| 2014-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $400.00K derived: sum of 2 quarters · filed 2017-03-01 | $1.00M derived: sum of 3 quarters · filed 2017-03-01 | $3.20M 10-K · filed 2017-03-01 |
| 2014-09-30 | $300.00K 10-Q · filed 2015-11-06 | $900.00K derived: sum of 2 quarters · filed 2015-11-06 | $3.10M 10-Q · filed 2015-11-06 | $3.90M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $600.00K 10-Q · filed 2015-08-07 | $2.80M 10-Q · filed 2015-08-07 | $3.60M derived: sum of 3 quarters · filed 2016-02-29 | $4.30M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $2.20M 10-Q · filed 2015-05-08 | $3.00M derived: sum of 2 quarters · filed 2016-02-29 | $3.70M derived: sum of 3 quarters · filed 2016-02-29 | $6.10M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.50M derived: sum of 2 quarters · filed 2016-02-29 | $3.90M derived: sum of 3 quarters · filed 2016-02-29 | $6.10M 10-K · filed 2016-02-29 |
| 2013-09-30 | $700.00K 10-Q · filed 2014-11-07 | $3.10M derived: sum of 2 quarters · filed 2014-11-07 | $5.30M 10-Q · filed 2014-11-07 | $8.20M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $2.40M 10-Q · filed 2014-08-08 | $4.60M 10-Q · filed 2014-08-08 | $7.50M derived: sum of 3 quarters · filed 2015-02-27 | $11.00M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $2.20M 10-Q · filed 2014-05-09 | $5.10M derived: sum of 2 quarters · filed 2015-02-27 | $8.60M derived: sum of 3 quarters · filed 2015-02-27 | $10.80M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $6.40M derived: sum of 2 quarters · filed 2015-02-27 | $8.60M derived: sum of 3 quarters · filed 2015-02-27 | $11.10M 10-K · filed 2015-02-27 |
| 2012-09-30 | $3.50M 10-Q · filed 2013-11-08 | $5.70M derived: sum of 2 quarters · filed 2013-11-08 | $8.20M 10-Q · filed 2013-11-08 | $9.30M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $2.20M 10-Q · filed 2013-08-08 | $4.70M 10-Q · filed 2013-08-08 | $5.80M derived: sum of 3 quarters · filed 2014-02-27 | $7.80M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $2.50M 10-Q · filed 2013-05-09 | $3.60M derived: sum of 2 quarters · filed 2014-02-27 | $5.60M derived: sum of 3 quarters · filed 2014-02-27 | $6.80M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $3.10M derived: sum of 2 quarters · filed 2014-02-27 | $4.30M derived: sum of 3 quarters · filed 2014-02-27 | $4.30M 10-K · filed 2014-02-27 |
| 2011-09-30 | $2.00M 10-Q · filed 2012-11-08 | $3.20M derived: sum of 2 quarters · filed 2012-11-08 | $3.20M 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $1.20M 10-Q · filed 2012-08-09 | $1.20M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |